Thursday, 17 Oct 2019

Treating C. difficile infections: New purpose for an old drug?

Common in hospitals and nursing homes, Clostridioides difficile infection (CDI) is a major health threat, particularly for older patients. According to a 2015 study by the Centers for Disease Control and Prevention, in the U.S. the infection claims some 15,000 lives per year. Certain antibiotics, by disrupting normal gut microorganisms (microbiota), create an opening for the […]

Misused and overprescribed: Issues with anxiety drug persist despite 2017 policy

A national policy to curb inappropriate use and prescribing of anxiety drug alprazolam—more commonly known as Xanax—has not had the desired effect, a team of researchers led by UNSW Medicine’s Centre for Big Data Research in Health has found. In their study—published today in JAMA Network Open—the team analyzed a range of data sources relating […]

Tentative opioid deal won’t end court battles for Purdue

Courtroom showdowns still face OxyContin maker Purdue Pharma and the family that owns it, the Sacklers. But after a tentative settlement reached Wednesday with thousands of local governments and more than 20 states, the fight will be less about the damage done by the company and more over how to divide its assets. The agreement […]

Compound offers prospects for preventing acute kidney failure

Russian researchers from the Moscow Institute of Physics and Technology, the Institute of Cell Biophysics, and elsewhere have shown an antioxidant compound known as peroxiredoxin to be effective in treating kidney injury in mice. The study in Cell and Tissue Research reports tripled survival rates in test animals treated with the chemical prior to sustaining […]

Email: Opioid talks fail, Purdue bankruptcy filing expected

OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation’s deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday. The breakdown puts the first federal trial over the opioid epidemic on track to begin next month, likely without Purdue, and sets the stage for […]

CDC: January to July 2018 saw decrease in opioid deaths

Opioid deaths decreased during January to July 2018, while deaths from illicitly manufactured fentanyl (IMF) increased during the same period, according to research published in the Aug. 30 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Noting that provisional estimates of the number of opioid deaths for 2018 […]

‘Miracle mineral solution’ is no miracle cure, FDA warns

Miracle Mineral Solution, which is sold online as a medical treatment, can cause serious and potentially life-threatening health problems and should not be bought or used by consumers, the U.S. Food and Drug Administration says. The agency has not approved the product for any use, but it is marketed on social media as a remedy […]

Brand-brand competition is unlikely to reduce list prices of medicines

Greater brand-brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women’s Hospital and Harvard Medical School, and colleagues. US prescription drug spending has increased sharply over the last decade, with […]

Study finds new insights on overdose rates, county segregation, and socioeconomics

A new study led by George Mason University’s College of Health and Human Services found new insights into the link between county socioeconomics and segregation on drug overdose deaths. The study found that socioeconomic factors and segregated counties may affect the rate of drug overdose deaths independently and differently among racial and ethnic groups. This […]

Recent Posts